Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Why Moderna Was a Stock Market Star on Friday
08:41pm, Friday, 29'th Jul 2022 The Motley Fool
The biotech keeps up a steady supply of coronavirus vaccine boosters to a very reliable customer.
L.A. County dodges face-mask mandate as community transmission rates stabilize, and U.S. government orders 66 million doses of Moderna's pending booster
05:07pm, Friday, 29'th Jul 2022 MarketWatch
Los Angeles County has dropped a plan for a universal indoor face mask mandate as COVID cases and hospitalizations have stabilized, with community transmission expected to fall to "medium" from "high"
Retooled, omicron-specific COVID boosters expected in September: report
01:34am, Friday, 29'th Jul 2022 MarketWatch
Biden administration decides those under 50 should wait for the new shot for their second booster
Amicus Therapeutics (FOLD) Expected to Beat Earnings Estimates: Should You Buy?
02:02pm, Thursday, 28'th Jul 2022 Zacks Investment Research
Amicus Therapeutics (FOLD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Missed Out on Vaccine Stocks? My Best Biotech Stock to Buy and Hold
10:00am, Thursday, 28'th Jul 2022 The Motley Fool
This company has 46 treatment programs in development.
Earnings Preview: Moderna (MRNA) Q2 Earnings Expected to Decline
02:02pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Moderna (MRNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Do Some of My Favorite S&P 500 Stocks Have In Common? They're All REITs
11:10am, Wednesday, 27'th Jul 2022 The Motley Fool
A cell tower company, a lab space owner, a data-center operator, and "The Monthly Dividend Company" are on this shortlist.
Where Will Novavax Be in 3 Years?
02:53pm, Tuesday, 26'th Jul 2022 The Motley Fool
A lot is riding on how effectively it can penetrate the market for coronavirus booster shots.
3 Reasons Why Novavax Is a Better Stock to Buy Than Moderna
09:55am, Tuesday, 26'th Jul 2022 The Motley Fool
Novavax offers several clear advantages over its larger rival.
Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know
09:45pm, Monday, 25'th Jul 2022 Zacks Investment Research
In the latest trading session, Moderna (MRNA) closed at $165.69, marking a +1.33% move from the previous day.
Wall Street Breakfast: Earnings Onrush
12:56pm, Monday, 25'th Jul 2022 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.
Moderna And 2 Other Stocks Insiders Are Selling
11:45am, Monday, 25'th Jul 2022 Benzinga
US manufacturing PMI dropped to 52.3 in July from previous reading of 52.70, while services PMI tumbled to 47.00 from 52.70. Investors, meanwhile, focused on some notable insider trades.
When insiders
1 Beaten-Down Growth Stock To Avoid Like the Plague
11:40am, Sunday, 24'th Jul 2022 The Motley Fool
The last few years haven't been kind to Inovio Pharmaceuticals.
Vanguard's new 'impact fund' targets social and environmental change, not just financial performance
07:00pm, Saturday, 23'rd Jul 2022 MarketWatch
Impact funds like Vanguard Baillie Gifford Global Positive Impact Stock Fund are a form of ESG funds.
Here is What to Know Beyond Why Moderna, Inc. (MRNA) is a Trending Stock
01:00pm, Friday, 22'nd Jul 2022 Zacks Investment Research
Moderna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
